Mehboob Hoque

Dr. Mehboob Hoque

Aliah University, Kolkata, India
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Pharmacological Research
Verified
Journal Article
Closed access
MAMohammad Azam Ansari
Mohammad Azam Ansari
FKFarheen Badrealam Khan
Farheen Badrealam Khan
HSHaaris Ahsan Safdari
Haaris Ahsan Safdari
AAAhmad Almatroudi
Ahmad Almatroudi
MAMohammad A Alzohairy
Mohammad A Alzohairy
MHMehboob Hoque
Mehboob Hoque

Verified
Journal Article
Open access
PDF file
IAIftikhar Ahmad
Iftikhar Ahmad
MHMehboob Hoque
Mehboob Hoque
SASyed Sahajada Mahafujul Alam
Syed Sahajada Mahafujul Alam
TZTorki Zughaibi
Torki Zughaibi
STShams Tabrez
Shams Tabrez
Cancer development is associated with the deregulation of various cell signaling pathways brought on by certain genetic and epigenetic alterations. Therefore, novel therapeutic strategies have been developed to target those pathways. The phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) (PI3K/Akt/mTOR) pathway is one major deregulated pathway in various types of cancer. Several anticancer drug candidates are currently being investigated in preclinical and/or clinical studies to target this pathway. Natural bioactive compounds provide an excellent source for anticancer drug development. Curcumin and plumbagin are two potential anticancer compounds that have been shown to target the PI3K/Akt/mTOR pathway individually. However, their combinatorial effect on cancer cells is still unknown. This study aims to investigate the synergistic effect of these two compounds on the PI3K/Akt/mTOR pathway by employing a sequential molecular docking and molecular dynamics (MD) analysis. An increase in binding affinity and a decrease in inhibition constant have been observed when curcumin and plumbagin were subjected to sequential docking against the key proteins PI3K, Akt, and mTOR. The MD simulations and molecular mechanics combined with generalized Born surface area (MM-GBSA) analyses validated the target proteins’ more stable conformation when interacting with the curcumin and plumbagin combination. This indicates the synergistic role of curcumin and plumbagin against cancer cells and the possible dose advantage when used in combination. The findings of this study pave the way for further investigation of their combinatorial effect on cancer cells in vitro and in vivo models.

1 February 2021 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
JGJyoti Gupta
Jyoti Gupta
HSHaaris Ahsan Safdari
Haaris Ahsan Safdari
MHMehboob Hoque
Mehboob Hoque

1 November 2015 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
EAEjaj Ahmad
Ejaj Ahmad
MFMunazza Tamkeen Fatima
Munazza Tamkeen Fatima
MHMehboob Hoque
Mehboob Hoque
MOMohammad Owais
Mohammad Owais
MSMohammed Saleemuddin
Mohammed Saleemuddin

11 September 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MHMehboob Hoque
Mehboob Hoque
SDSandeep Dave
Sandeep Dave
PGPawan Gupta
Pawan Gupta
MSMohammed Saleemuddin
Mohammed Saleemuddin
A chance discovery of the tumoricidal action of a human milk fraction led to the characterization of the active component as oleic acid complex of the α-lactalbumin, which was given the acronym HAMLET. We report in this study that the oleic acid complex of bovine α-lactalbumin (BAMLET) is hemolytic to human erythrocytes as well as to those derived from some other mammals. Indirect immunofluorescence analysis suggested binding of BAMLET to erythrocytes prior to induction of hemolysis. Free OA was hemolytic albeit at higher concentrations, while sodium oleate caused hemolysis at far lower concentrations. Amiloride and BaCl2 offered protection against BAMLET-induced hemolysis suggesting the involvement of a cation leak channel in the process. BAMLET coupled to CNBr-activated Sepharose was not only hemolytic but also tumoricidal to Jurkat and MCF-7 cells in culture. The Sepharose-linked preparation was however not toxic to non-cancerous peritoneal macrophages and primary adipocytes. The tumoricidal action was studied using the MTT-assay while apoptosis induction measured by the annexin V-propidium iodide assay. Repeated incubation of the immobilized BAMLET with erythrocytes depleted oleic acid and decreased the hemolytic activity of the complex. Incubation of MCF-7 and Jurkat cells with OA, soluble or immobilized BAMLET resulted in increase in the uptake of Lyso Tracker Red and Nile red by the cells. The data presented support the contention that oleic acid plays the key role, both in BAMLET-induced hemolysis and tumoricidal action.

8 August 2022 in Molecules
Verified
Journal Article
Open access
PDF file
STShams Tabrez
Shams Tabrez
TZTorki Zughaibi
Torki Zughaibi
MHMehboob Hoque
Mehboob Hoque
MSMohd Suhail
Mohd Suhail
MKMohammad Imran Khan
Mohammad Imran Khan
AKAzhar U. Khan
Azhar U. Khan
Cancer cells change their glucose and glutamine (GLU) metabolism to obtain the energy required to continue growing. Glutaminase (GLS) plays a crucial role in promoting cell metabolism for cancer cell growth; targeting GLU metabolism by inhibiting GLS has attracted interest as a potential cancer management strategy. Herein, we employed a sequential screening of traditional Chinese medicine (TCM) database followed by drug-likeness and molecular dynamics simulations against the active site of GLS. We report 12 potent compounds after screening the TCM database against GLS, followed by a drug-likeness filter with Lipinski and Veber rule criteria. Among them, ZINC03978829 and ZINC32296657 were found to have higher binding energy (BE) values than the control compound 6-Diazo-5-Oxo-L-Norleucine, with BEs of −9.3 and −9.7 kcal/mol, respectively, compared to the BE of 6-Diazo-5-Oxo-L-Norleucine (−4.7 kcal/mol) with GLS. Molecular dynamics simulations were used to evaluate the results further, and a 100 ns MD simulation revealed that the hits form stable complexes with GLS and formed 2–5 hydrogen bond interactions. This study indicates that these hits might be employed as GLS inhibitors in the battle against cancer. However, more laboratory tests are a prerequisite to optimize them as GLS inhibitors.